Principles of drug absorption

Modern Pharmaceutics, Fourth Edition, Revised and Expanded

Volumn , Issue , 2002, Pages 29-93

  Mayersohn, Michael ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056967224     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (157)

1. JD Verhoff, HE Bodde, AG deBoer, JA Bouwstra, HE Junginger, FWHM Merkus DD Breimer. Transport of peptide and protein drugs across biological membranes. Eur J Drug Metab Pharmacokin 15:83-93, 1990.
2. PA Wender, DJ Mitchell, K Pattabiraman, ET Pelkey, L Steinman, JB Rothbard. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters. Proc Natl Acad Sci USA 97:13003-13008, 2000.
3. JB Rothbard, S Garlington, Q Lin, T Kirschberg, E Kreider, PL McGrane, PA Wender, PA Khavari. Conjugation of arginine digomers to cyclosporin: A facilitates topical delivery and inhibition of inflammation. Nat Med 6:1253-1257, 2000.
4. JW Hole. Human Anatomy and Physiology. 2nd ed. Dubuque, IA: Wm. C. Brown Company, 1981, p. 414.
5. H Leonhardt. Color Atlas/Text of Human Anatomy. Vol. 2. 4th ed. New York: Thieme Medical Publishers, 1993, p. 213.
6. T Fujita, K Tanaka, J Tokunaga. SEM Atlas of Cells and Tissues. New York: Igaku-Shoin, 1981, pp. 122, 123, 129.
7. JW Hole. In: SEM Atlas of Cells and Tissues. New York: Igaku-Shoin, 1981, p. 439.
8. JS Trier. Morphology of the epithelium of the small intestine. In: CF Code, ed. Handbook of Physiology. Vol. III, Intestinal Absorption. Washington, DC: American Physiological Society,1968, p. 1133.
9. T Fujita, K Tanaka, J Tokunaga. In: CF Code, ed. Handbook of Physiology. Washington DC: American Physiological Society, 1968, p. 135.
10. GJ Tortora, NP Anagnostakos. Principles of Anatomy and Physiology. 6th ed. New York: Harper and Row, 1990, p. 770.
11. JS Fordtran, FC Rector, Jr., MF Ewton, N Soter, J Kinney. Permeability characteristics of the human small intestine. J Clin Invest 44:1935-1944, 1965.
12. JF Danielli, H Davson. A contribution to the theory of permeability of thin films. J Cell Comp Physiol 5:495-508, 1935.
13. H Davson, JF Danielli. The Permeability of Natural Membranes. 2nd ed. New York: Cambridge University Press, 1952.
14. LC Junqueira, J Carneiro, RO Kelley. Basic Histology. 6th ed. East Norwalk, CT: Appleton and Lange, 1989, p. 32.
15. R Hober, J Hober. Experiments on the absorption of organic solutes in the small intestine of rats. J Cell Comp Physiol 10:401-422, 1937.
16. LS Schanker. Absorption of drugs from the rat colon. J Pharmacol Exp Ther 126:283-290, 1959.
17. EM Wright, JM Diamond. Patterns of non-electrolyte permeability. Proc Royal Soc B 172:203-225, 1969.
18. EM Wright, JM Diamond. Patterns of non-electrolyte permeability. Proc Royal Soc B 172:227-271, 1969.
19. JM Diamond, EM Wright. Molecular forces governing nonelectrolyte permeation through cell membranes. Proc Royal Soc B 172:273-316, 1969.
20. CA Lipinski, F Lombardo, BW Dominy, PF Feeney. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3-25, 1997.
21. Y Yoshimura, N Kakeya. Structure-gastrointestinal absorption relationship of penicillins. Int J Pharm 17:47-57, 1983.
22. T Sollmann. The comparative efficiency of local anesthetics. J Am Med Assoc 70:216-219, 1918.
23. JM Faulkner. Nicotine poisoning by absorption through the skin. J Am Med Assoc 100:1664-1665, 1933.
24. J Travell. The influence of the hydrogen ion concentration on the absorption of alkaloids from the stomach. J Pharmacol Exp Ther 69:21-33, 1940.
25. MH Jacobs. Some aspects of cell permeability to weak electrolytes. Cold Spring Harbor Symp Quant Biol 8:30-399, 1940.
26. PA Shore, BB Brodie, CAM Hogben. The gastric secretion of drugs: a pH partition hypothesis. J Pharmacol Exp Ther 119:361-369, 1957.
27. LS Schanker, PA Shore, BB Brodie, CAM Hogben. Absorption of drugs from the stomach. I. The rat. J Pharmacol Exp Ther 120:528-539, 1957.
28. CAM Hogben, LA Schanker, DJ Tocco, BB Brodie. Absorption of drugs from the stomach. II. The human. J Pharmacol Exp Ther 120:540-545, 1957.
29. LS Schanker, DJ Tocco, BB Brodie, CAM Hogben. Absorption of drugs from the rat small intestine. J Pharmacol Exp Ther 123:81-87, 1958.
30. CAM Hogben, DJ Tocco, BB Brodie, LS Schanker. On the mechanism of intestinal absorption of drugs. J Pharmacol Exp Ther 125:275-282, 1959.
31. JT. Doluisio, NF Billups, LW Dittert, ET Sugita, JV Swintosky. Drug absorption. I. An in situ rat gut technique yielding realistic absorption rates. J Pharm Sci 58:1196-1200, 1969.
32. LZ Benet. Biopharmaceutics as a basis for the design of drug products. In: EJ Ariens, ed. Drug Design, Vol. 4. New York: Academic Press, 1973, pp. 26-28.
33. DS Riggs. The Mathematical Approach to Physiological Problems. Baltimore: Williams & Wilkins, 1963, pp. 181-185.
34. GL Flynn, SK Yalkowsky, TJ Roseman. Mass transport phenomena and models: theoretical concepts. J Pharm Sci 63:479-510, 1974.
35. M Mayersohn. Drug absorption. J Clin Pharmacol 27:634-638, 1987.
36. Y-L He, S Murby, G Warhurst, L Gifford, D Walker, J Ayrton, R Eastmond, M Rowland. Species differences in size discrimination in the paracellular pathway reflected by oral bioavailability of poly (ethylene glycol) and D-peptides. J Pharm Sci 87: 626-633, 1998.
37. LS Schanker, JJ Jeffrey. Active transport of foreign pyrimidines across the intestinal epithelium. Nature 190:727-728, 1961.
38. DF Evered, HG Randall. The absorption of amino acid derivatives of nitrogen mustard from rat intestine in vitro. Biochem Pharmacol 11:371-376, 1962.
39. G Levy, WJ Jusko. Factors affecting the absorption of riboflavin in man. J Pharm Sci 55:285-289, 1966.
40. M Mayersohn. Ascorbic acid absorption in manpharmacokinetic implications. Eur J Pharmacol 19:140-142, 1972.
41. NG Gillespie, I Mena, GC Cotzias, MA Bell. Diets affecting treatment of parkinsonism with levodopa. J Am Diet Assoc 62:525-528, 1973.
42. DN Wade, PT Mearrick, JL Morris. Active transport of L-Dopa in the intestine. Nature 242:463-465, 1973.
43. MH van Woert. Phenylalanine and tyrosine metabolism in Parkinson’s disease treated with levodopa. Clin Pharmacol Ther 12:368-375, 1971.
44. H Lennernas, D Nilsson, S-M Aquilonius, D Ahrenstedt, L Knutson, LK Paalzow. The effect of L-leucine on the absorption of levodopa, studied by regional jejunal perfusion in man. Br J Clin Pharmacol 35:343-250, 1993.
45. J Zimmerman. Methotrexate transport in the human intestine. Biochem Pharmacol 43:2377-2383, 1992.
46. J-F Westphal, J-H Trouvin, A Deslandes, C Carbon. Nifedipine enhances amoxicillin absorption kinetics and bioavailability in human. J Pharmacol Exp Ther 255:312-317, 1990.
47. C Duverne, A Bouten, A Deslandes, J-F Westphal, J-H Trouvin, R Farinotti, C Carbon. Modification of cifixime bioavailability by nifedipine in humans: involvement of the dipeptide carrier system. Antimicrob Agents Chemother 36:2462-2467, 1992.
48. BH Stewart, AR Kugler, PR Thompson, NN Bockbrader. A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma. Pharmaceut Res 10:276-281, 1993.
49. II Gottesman, I Pastan. Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann Rev Biochem 62:385-427, 1993.
50. Y Tanigawara. Role of p-glycoprotein in drug disposition. Ther Drug Monitor 22:137-140, 2000.
51. JV Asperen, OV Tellingen, JH Beijnen. The pharmacological role of p-glycoprotein in the intestinal epithelium. Pharmacol Res 37:429-435, 1998.
52. V Wacher, JA Silverman, Y Zhang, LZ Benet. Role of p-glycoprotein and cytochrome P4503A in limiting oral absorption of peptides and peptidomimetics. J Pharm Sci 87:1322-1330, 1998.
53. J Wacher, L Salphati, LZ Benet. Active secretion and enterocyte drug metabolism barriers to drug absorption. Adv Drug Del Rev 20:99-112, 1996.
54. A Sparreboom, J van Asperen, U Mayer, AH Schinkel, JW Smit, DKF Meijer, P Borst, WJ Nooijen, JH Beijnen, O van Tillingen. Limited oral bioavailability of taxol and active epithelial secretion of paclitaxel (Taxol) caused by p-glycoprotein in the intestine. Proc Nat Acad Sci USA 94:2031-2035, 1997.
55. K Westphal, A Weinbrenner, T Giessmann, M Stuhr, G Franke, M Zschiesche, R Oertel, B Terhaag, HK Kroemer, W Siegmund. Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal p-glycoprotein. Clin Pharmacol Ther 68:6-12, 2000.
56. JB Dressman, GL Amidon, C Reppas, VP Shah. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm Res 15:11-22, 1998.
57. TR Bates, JM Young, CM Wu, HA Rosenberg. pH-dependent dissolution rate of nitrofurantoin from commercial suspensions, tablets and capsules. J Pharm Sci 63:643-645, 1974.
58. G Levy, BA Sahli. Comparison of the gastrointestinal absorption of aluminum acetylsalicylate and acetylsalicylic acid in man. J Pharm Sci 51:58-62, 1962.
59. G Levy, JA Procknal. Unusual dissolution behavior due to film formation. J Pharm Sci 51:294, 1962.
60. CE Blezek, JL Lach, JK Guillory. Some dissolution aspects of ferrous sulfate tablets. Am J Hosp Pharm 27:533-539, 1970.
61. RG Crounse. Human pharmacology of griseofulvin. The effect of fat intake on gastrointestinal absorption. J Invest Dermatol 37:529-533, 1961.
62. M Kraml, J Dubuc, D Beall. Gastrointestinal absorption of griseofulvin. I. Effect of particle size, addition of surfactants and corn oil on the level of griseofulvin in the serum of rats. Can J Biochem Physiol 40:1449-1451, 1962.
63. AJ Moes. Gastroretentive dosage forms. Crit Rev Therap Drug Carrier Sys 10:143-195, 1993.
64. H Minami, RW McCallum. The physiology and pathophysiology of gastric emptying in humans. Gastroenterol 86:1592-1610, 1984.
65. AG Renwick, CH Ahsan, VF Challenor, R Daniels, BS MacKlin, DG Waller, CF George. The influence of posture on the pharmacokinetics of orally administered nifedipine. Br J Clin Pharmacol 34:332-336, 1992.
66. A Hopkins. The pattern of gastric emptying: a new view of old results J Physiol 182:144-149, 1966.
67. JD Elashoff, TJ Reedy, JH Meyer. Analysis of gastric emptying data. Gastroenterology 83:1306-1312, 1982.
68. RH Blythe, GM Grass, DR MacDonnell. The formulation and evaluation of enteric coated aspirin tablets. Am J Pharm 131:206-216, 1959.
69. M Alpsten, C Bogentoft, G Ekenved, L Solveil. Gastric emptying and absorption of acetylsalicylic acid administered as enteric-coated micro-granules. Eur J Clin Pharmacol 22:57-61, 1982.
70. P Welling. Effects of food on drug absorption. Ann Rev Nutr 16:383-415, 1996.
71. D Fleisher, C Li, Y Zhou, L-H Pao, A Karim. Drug, meal and formulation interactions influencing drug absorption after oral administration. Clin Pharmacokin 36:233-254, 1999.
72. WN Charman, CJH Porter, S Mithani, JB Dressman. Physicochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J Pharm Sci 86:269-282, 1997.
73. L Hendeles, M Weinberger, G Milavetz, M Hill III, L Vaughan. Food-induced ‘dose-dumping’ from a oncea-day theophylline product as a cause of theophylline toxicity. Chest 87:758-765, 1985.
74. MN Gai, A Isla, MT Andonaegui, AM Thielemann, C Seitz. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets. Int J Clin Pharmacol Ther 35:565-571, 1997.
75. TR Bates, JA Sequeira, AV Tembo. Effect of food on nitrofurantoin absorption. Clin Pharmacol Ther 16:63-68, 1974.
76. HA Rosenberg, TR Bates. The influence of food on nitrofurantoin bioavailability. Clin Pharmacol Ther 20:227-232, 1976.
77. S Yung, M Mayersohn, JB Robinson. Ascorbic acid absorption in man: influence of divided dose and food. Life Sci 28:2505-2511, 1981.
78. CW Meuhlberger. The physiological action of alcohol. J Am Med Assoc 167:1842-1845, 1958.
79. J Fermaglich, S O’Doherty. Effect of gastric motility on levodopa. Dis Nerv Syst 33:624-625, 1972.
80. M Siurala, O Mustala, J Jussila. Absorption of acetylsalicylic acid by a normal and strophic gastric mucosa. Scand J Gastroenterol 4:269-273, 1969.
81. M Kekki, K Pyorola, O Justala, H Salmi, J Jussila, M Siurala. Multicompartment analysis of the absorption kinetics of warfarin from the stomach and small intestine. Int J Clin Pharmacol 5:209-214, 1971.
82. RC Heading, J Nimmo, LF Prescott, P Tothill. The dependence of paracetamol absorption on the rate of gastric emptying. Br J Pharmacol 47:415-421, 1973.
83. LF Prescott, WS Nimmo, RC Heading. Drug absorption interactions. In: DG Grahame-Smith, ed. Drug Interactions. Baltimore: Macmillan, 1977, p. 45.
84. KS Channer, J Virjee. Effect of posture and drink volume on the swallowing of capsules. Br Med J 285:1702, 1982.
85. H Hey, F Jorgenson, K Sorensen, H Hasselbalch, T Wamberg. Oesophageal transit of six commonly used tablets and capsules. Br Med J 285:171-179, 1982.
86. KS Channer, CJC Roberts. Effect of delayed esophageal transit on acetaminophen absorption. Clin Pharmacol Ther 37:72-76, 1985.
87. SS Davis, JG Hardy, JW Fara. Transit of pharmaceutical dosage forms through the small intestine. Gut 27:886-892, 1986.
88. JL Madsen. Effects of gender, age, and body mass index on gastrointestinal transit times. Digest Dis Sci 37:1548-1553, 1992.
89. JMC Price, SS Davis, IR Wilding. The effect of fibre on gastrointestinal transit times in vegetarians and omnivores. Int J Pharmaceut 76:123-141, 1991.
90. F Pirk. Changes in the motility of the small intestine in digestive disorders. Gut 8:486-490, 1967.
91. AC Guyton. Basic Human Physiology: Normal Functions and Mechanisms of Disease. Philadelphia: WB Saunders, 1971, p. 428.
92. E Parry, R Shields, AC Turnbull. Transit time in the small intestine in pregnancy. J Obstet Gynaecol 77:900-901, 1970.
93. AM Metcalf, SF Phillips, AR Zinsmeister, RL MacCarty, RW Beart, BG Wolff. Simplified assessment of segmental colonic transit. Gastroenterology 92:40-47, 1987.
94. PJ Watts, L Barrow, KP Steed, CG Wilson, RC Spiller, CD Melia, MC Davis. The transit rate of different sized model dosage forms through the human colon and the effects of a lactuloseinduced catharsis. Int J Pharmaceut 87:215-221, 1992.
95. DA Akin, SS Davis, RA Sparrow, IR Wilding. Colonic transit of different sized tablets in healthy subjects. J Controlled Release 23:147-156, 1993.
96. JMC Price, SS Davis, RA Sparrow, IR Wilding. The effect of meal composition on the gastrocolonic response: implications for drug delivery to the colon. Pharmaceut Res 10:722-726, 1993.
97. CJ McDougall, R Wong, P Scudera, M Lesser, JJ De Cosse. Colonic mucosal pH in humans. Digest Dis Sci 38:542-545, 1993.
98. DR Friend. Colon-specific drug delivery. Adv Drug Del Rev 7:149-199, 1991.
99. KH Antonin, V Saano, P Bleck, J Hastewell, R Fox, P Low, M MacKay. Colonic absorption of human calcitonin in man. Clin Sci 83:627-631, 1992.
100. MF Williams, GF Dukes, W Heizer, Y-H Han, DJ Hermann, T Lampkin, LJ Hak. Influence of gastrointestinal site of drug delivery on the absorption characteristics of ranitidine. Pharmaceut Res 9:1190-1194, 1992.
101. KKH Chan, A Buch, RD Glazer, VA John, WH Barr. Site-differential gastrointestinal absorption of benazepril hydrochloride in health volunteers. Pharmaceut Res 11:432-37, 1994.
102. L d’Agay-Abensour, A Fjellestad-Paulsen, P Hoglund, Y Ngo, O Paulsen, JC Rambaud. Absolute bioavailability of an aqueous solution of l-deamino-8-D-arginine vasopressin from different regions of the gastrointestinal tract in man. Eur J Clin Pharmacol 44:473-476, 1993.
103. PE Warner, KLR Brouwer, EK Hussey, GE Dukes, WD Heizer, KH Donn, IM Davis, JR Powell. Sumatriptan absorption from different regions of the human gastrointestinal tract. Pharmaceut Res 12:138-143, 1995.
104. AG De Boer, F Moolenaar, LGJ de Leede, DD Breimer. Rectal drug administration: clinical pharmacokinetic considerations. Clin Pharmacokinet 7:285-311, 1982.
105. D Winne. The influence of blood flow on the absorption of L-and D-phenylalanine from the jejunum of the rat. Arch Pharmacol 277:113-138, 1973.
106. D Winne. Formal kinetics of water and solute absorption with regard to intestinal blood flow. J Theoret Biol 2:1-18, 1970.
107. D Winne, J Remischovsky. Intestinal blood flow and absorption of nondissociable substances. J Pharm Pharmacol 22:640-641, 1970.
108. WG Crouthamel, L Diamond, LW Dittert, JT Doluisio. Drug absorption.VII. Influence of mesenteric blood flow on intestinal drug absorption in dogs. J Pharm Sci 64:664-671, 1975.
109. M Rowland, S Riegelman, PA Harris, SD Sholkoff. Absorption kinetics of aspirin in man following oral administration of an aqueous solution. J Pharm Sci 61:379-385, 1972.
110. E Kruger-Thiemer. Pharmacokinetics and dose-concentration relationships. In: EJ Ariens, ed. PhysicoChemical Aspects of Drug Action. Elmsford, NY: Pergamon Press, 1968, pp. 63-113.
111. GC Oliver, R Tazman, R Frederickson. Influence of congestive heart failure on digoxin level. In: O Storstein, ed. Symposium on Digitalis. Oslo: Gyldendal Norsk Forlag, 1973, pp. 336-347.
112. NL Benowitz. Effects of cardiac disease on pharmacokinetics: pathophysiologic considerations. In: LZ Benet, N Massoud, JG Gainbertoglio, eds. Pharmacokinetics Basis for Drug Treatment. New York: Raven Press, 1984, pp. 89-103.
113. MM Drucker, SJ Blondheim, L Wislicki. Factors affecting acetylation in vivo of paraaminobenzoic acid by human subjects. Clin Sci 27:133-141, 1964.
114. G Levy, T. Matsuzawa. Pharmacokinetics of salicylamide elimination in man. J Pharmacol Exp Ther 156:285-293, 1967.
115. KE Price, Z Zolli, Jr, JC Atkinson, HG Luther. Antibiotic inhibitors. I. The effect of certain milk constituents. Antibiot Chemother 7:672-688, 1957.
116. KE Price, Z Zolli, Jr, JC Atkinson, HG Luther. Antibiotic inhibitors. II. Studies on the inhibitory action of selected divalent cations for oxytetracyctine. Antibiot Chemother 7:689-701, 1957.
117. J Scheiner, WA Altemeier. Experimental study of factors inhibiting absorption and effective therapeutic levels of declomycin. Surg Gynecol Obstet 114:9-14, 1962.
118. PJ Neuvonen, H Turakka. Inhibitory effect of various iron salts on the absorption of tetracycline in man. Eur J Clin Pharmacol 7:357-360, 1974.
119. JG Wagner. Biopharmaceutics: absorption aspects. J Pharm Sci 50:359-387, 1961.
120. P Singh, JK Guillory, TD Sokoloski, LZ Benet, VN Bhatia. Effect of inert tablet ingredients on drug absorption. I. Effect of polyethylene glycol 4000 on the intestinal absorption of four barbiturates. J Pharm Sci 55:63-68, 1966.
121. S Riegelman, WJ Crowell. The kinetics of rectal absorption. II. The absorption of anions. J Am Pharm Assoc Sci Ed 47:123-127, 1958.
122. S Riegelman, WJ Crowell. The kinetics of rectal absorption. III. The absorption of undissociated molecules. J Am Pharm Assoc Sci Ed 47:127-133, 1958.
123. K Kakemi, T Arita, S Muranishi. Absorption and excretion of drugs. XXVII. Effect of nonionic surfaceactive agents on rectal absorption of sulfonamides. Chem Pllarm Bull 13:976-985, 1965.
124. DL Sorby. Effect of adsorbents on drug absorption. I. Modification of promazine absorption by activated attapulgite and activated charcoal. J Pharm Sci 54:677-683, 1965.
125. JG Wagner. Design and data analysis of biopharmaceutical studies in man. Canad J Pharm Sci 1:55-68, 1966.
126. DG Bailey, JD Spence, C Munoz, JMO Arnold. Interaction of citrus juices with felodipine and nifedipine. Lancet 337:268-269, 1991.
127. SD Hall, KE Thummel, PB Watkins, KS Lown, LZ Benet, MF Paine, RR Mayo, DK Turgeon, DG Bailey, RJ Fontana, SA Wrighton. Molecular and physical mecahnisms of first-pass extraction. Drug Metab Dispos 27:161-166, 1999.
128. DG Bailey, JMO Arnold, JD Spence. Inhibitors in the diet: grapefruit juice-drug interactions. In: RH Levy, KE Thummel, WE Trager, PD Hansten, M Eichelbaum, eds. Metabolic Drug Interactions: New York: Lippincott Williams & Wilkins, 2000, pp. 661-667.
129. P Schmeidlin-Ren, DJ Edwards, ME Fitzsimmons, K He, KS Lown, PM Woster, A Rahman, KE Thummel, JM Fisher, PF Hollenberg, PB Watkins. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents: decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metab Dispos 25:1228-1233, 1997.
130. GK Dresser, DG Bailey, SG Carruthers. Grapefruit juice-felodipine interaction in the elderly. Clin Pharmacol Ther 68:28-34, 2000.
131. CW Abruzzo, T Macasieb, R Weinfeld, JA Rider, SA Kaplan. Changes in the oral absorption characteristics in man of dipotassium clorasepate at normal and elevated gastric pH. J Pharmacokinet Biopharm 5:377-390, 1977.
132. L Rivera-Calimlim, CA Dujovne, JP Morgan, L Lasagna, JR Bianchine. Absorption and metabolism of L-dopa by the human stomach. Eur J Clin Invest 1:313-320, 1971.
133. L Fleckenstein, GR Mundy, RA Horovitz, JM Mazzullo. Sodium salicylamide: relative bioavailability and sujective effects. Clin.Pharmacol Ther 19:451-458, 1976.
134. G Levy, T Matsuzawa. Pharmacokinetics of salicylamide in man. J Pharmacol Ther 156:285-293, 1967.
135. MM Drucker, SJ Blondheim, L Wislicki, Factors affecting acetylation in vivo of paraaminobenzoic acid by human subjects. Clin Sci 27:133-141, 1964.
136. M Frezza, C Di Padova, G Pozzato, M Terpin, E Baraona, CS Lieber. High blood alcohol levels in women: the rold of decreased gastric alcohol dehydrogenase and first-pass metabolism. N Engl J Med 322:95-99, 1990.
137. HK Seitz, G Egerer, UA Simanowski, R Waldherr, R Eckey, DP Agarwal, HW Goedde, J-P von Wartourg. Human gastric alcohol dehydrogenase activity: effect of age, sex and alcoholism. Gut 34:1433-1437, 1993.
138. YK Tam. Individual variation in first-pass metabolism. Clin Pharmacokin 25:300-332, 1993.
139. RL Smith. The role of the gut flora in the conversion of inactive compounds to active metabolites. In: A Symposium on Mechanisms of Toxicity. WN Aldridge, ed. New York: Macmillan, 1971, pp. 228-244.
140. D Durr, B Stieger, GA Kullak-Ublick, KM Rentsch, HC Steinert, PJ Meier, K Fattinger. St. John’s wort induces intestinal p-glycoprotein/MDR1 and intestinal and hepatic CYP3A45. Clin Pharmacol Ther 68:598-604, 2000.
141. WA Ritschel, DD Denson. Influence of disease on bioavailability. In: PG Welling, FLS Tse, SV Dighe, eds. Pharmaceutical Bioequivalence. New York: Marcel Dekker, 1991, pp. 67-115.
142. PA Kramer, DJ Chapron, J Benson, SA Merik. Tetracycline absorption in elderly patients with achlorhydria. Clin Pharmacol Ther 23:467-472, 1978.
143. HR Ochs, DJ Greenblatt, HJ Dengler. Absorption of oral tetracycline in patients with Billroth-II gastrectomy. J Pharmacokinet Biopharm 6:295-303, 1978.
144. G Levy, MH MacGillivray, JA Procknal. Riboflavin absorption in children with thyroid disorders. Pediatrics 50:896-900, 1972.
145. LF Prescott. Gastrointestinal absorption of drugs. Med Clin North Am 58:907-916, 1974.
146. WJ Jusko, DR Conti, A Molson, P Kuritzky, J Giller, R Schultz. Digoxin absorption from tablets and elixir: the effect of radiation-induced malabsorption. J Am Med Assoc 230:1554-1555, 1974.
147. GH Sokol, DJ Greenblatt, BL Lloyd, A Gecrgotas, MD Allen, JS Harmatz, TW Smith, RI Shader. Effect of abdominal radiation therapy on drug absorption in humans. J Clin Pharmacol 18:388-396, 1978.
148. WD Heizer, TW Smith, SE Goldfinger. Absorption of digoxin in patients with malabsorption syndromes. N Engl J Med 285:257-259, 1971.
149. AE Davis, RC Pirola. Absorption of phenoxymethyl penicillin in patients with steatorrhea. Aust Ann Med 17:63-65, 1968.
150. JD Nelson, S Shelton, HT Kusmiesz, KC Haltalin. Absorption of ampicillin and nalidixic acid in infants and children with acute shigellosis. Clin Pharmacol Ther 13:879-886, 1972.
151. JP Kampmann, H Klein, B Lumholtz, JEM Hansen. Ampicillin and propylthiouracil pharmacokinetics in intestinal bypass patients followed up to a year after operation. Clin Pharmacokinet 9:168-176, 1984.
152. WJ Jusko, N Khanna, G Levy, L Stern, SJ Yaffe. Riboflavin absorption and excretion in the neonate. Pediatrics 45:945-949, 1970.
153. M Mayersohn. Special pharmacokinetic considerations in the elderly. In: WE Evans, JJ Schentag, WJ Jusko, eds. Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring. 3rd ed. Vancouver, WA: Applied Therapeutics, 1992, pp. 9-1-9-43.
154. M Mayersohn. Pharmacokinetics in the elderly. Environ Health Perspect 102 (suppl 11): 119-124, 1994.
155. M Mayersohn, The “xylose test” to assess gastrointestinal absorption in the elderly: a pharmacokinetic evaluation of the literature. J Gerontol 37:300-305, 1982.
156. SL Johnson, M Mayersohn, KA Conrad. Gastrointestinal absorption as a function of age: xylose absorption in healthy adult subjects. Clin Pharmacol Ther 38:331-335, 1985.
157. TL Russell, RR Berardi, JL Barnett, TL O’Sullivan, JG Wagner, JB Dressman. pH-related changes in the absorption of dipyridamole in the elderly. Pharmaceut Res 11:136-143, 1994.